Back to Search
MADHAVI THOMAS, M.D.
M.D.
Neurology Physician
NPI: 1558337238IndividualAccepts Medicare
Education
OTHER
Class of 1992
Research & Publications (20)
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.
PMID 19139433·J Clin Oncol·2009
3-trial
Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
PMID 17164111·Crit Rev Oncol Hematol·2007
6-review
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
PMID 17623837·Cancer·2007
3-trial
Long-term prognosis of patients with psychogenic movement disorders.
PMID 16737838·Parkinsonism Relat Disord·2006
8-other
I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
PMID 16278330·Am J Health Syst Pharm·2005
4-observational
Clinical gait and balance scale (GABS): validation and utilization.
PMID 14675615·J Neurol Sci·2004
4-observational
Minocycline: neuroprotective mechanisms in Parkinson's disease.
PMID 14965330·Curr Pharm Des·2004
6-review
Adrenocortical cell transplantation in scid mice: the role of the host animals' adrenal glands.
PMID 12943714·J Steroid Biochem Mol Biol·2003
7-preclinical
Human adrenocortical cell xenotransplantation: model of cotransplantation of human adrenocortical cells and 3T3 cells in scid mice to form vascularized functional tissue and prevent adrenal insufficiency.
PMID 12005105·Xenotransplantation·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 4931 LONG PRAIRIE RD STE 100
FLOWER MOUND, TX 75028 - Phone
- (817) 886-0369
Quick Facts
- NPI
- 1558337238
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile